CFO Andy Sassine to depart Dec 31, 2025; Controller Joe Roberts named interim CFO

Arcturus Therapeutics Holdings Inc.

CFO Andy Sassine and Arcturus mutually agreed to end employment effective Dec 31, 2025; he also resigned from the Board.
Sassine receives severance: 12 months base salary ($572,000), bonus tied to CEO's 2025 bonus, 18 months COBRA, and full acceleration of 134,689 unvested stock options with 24-month exercise period.
Joe Roberts, company Controller since March 2024, appointed interim principal financial and accounting officer; base salary $219,580, 20% target bonus.
Board size reduced from nine to eight members effective immediately upon Sassine's resignation.
Separation Agreement includes non-disparagement, standard release, and revocation period; severance contingent on release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.